ESCRS - Mysterious maculopathy case study ;
ESCRS - Mysterious maculopathy case study ;

Mysterious maculopathy case study

Diagnosis in this true mystery evaded everyone in attendance

Mysterious maculopathy case study
Leigh Spielberg
Leigh Spielberg
Published: Tuesday, September 12, 2017
[caption id="attachment_9441" align="alignright" width="1024"] Laura Kuehlewein[/caption] Dr Laura Kuehlewein, University Clinic Tübingen, Germany, presented a particularly challenging case during the Mystery Cases session of the first Young Retinal Specialists (YOURS) Day on Friday at the 17th Annual EURETINA conference. It’s fair to say that her case, entitled “Mysterious Maculopathy”, provided the audience with a true mystery, the diagnosis of which evaded everyone in attendance. It concerned a 54-year-old female with long-standing, bilaterally decreased visual acuity (20/200 in both eyes). She presented due to flicker scotomas upon awakening for the previous two months. She was hyperopic (+2.25) and had distorted pupils ODS. Fundus examination revealed extensive lesions resembling hard exudates, OS>OD, but there was no diabetes or arterial hypertension. There was hypoautofluorescence centrally and along the arcades ODS, and flourescein angiography showed early-phase, well demarcated hyperfluorescent lesions that did not increase in size in the later phases. The optic discs were normal. OCT displayed outer retinal atrophy ODS, with retinal pigment epithelial detachments, both large and small, OS>OD. Further questioning revealed similar symptoms in her sister. Genetic testing revealed a homozygotic BEST1 mutation. This led to the diagnosis of autosomal recessive bestrophinopathy. There was a silence in the auditorium, which likely made everyone feel better that no one else had thought of this diagnosis. After all, fewer than 20 such cases have been described worldwide. After a moment or two, a delegate stood up and asked, “How much time passed between initial presentation and final diagnosis?” “Years,” answered Dr Kuehlewein.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;